Do tumors have functioning mitochondria?

In summary, Otto Heinrich Warburg believed that cancer cells generate their ATP primarily from anaerobic metabolism. He was awarded the Nobel Prize in Physiology in 1931.
  • #1
treehouse
105
0
While I have not yet found a satisfactory description of his research methods, I am aware that at the Nobel Prize winning biologist Otto Heinrich Warburg believed at least from 1924 to 1966 that cancer cells generate their ATP primarily from anaerobic metabolism. He was awarded the Nobel Prize in Physiology in 1931.*

If supplied with the same amounts of the same reagents healthy cells use to make ATP, can tumors make as much ATP as healthy cells? What I am wondering is whether tumors' low rate of aerobic metabolism is due to a poverty of supply or an intrinsic inability.

*http://nobelprize.org/nobel_prizes/medicine/laureates/1931/warburg.html
 
Biology news on Phys.org
  • #2
Although the Warburg effect is a well established phenomenon, we don't really understand why cancer cells tend to switch to anaerobic metabolism. One reason could very well be a "poverty of supply." Solid tumors, especially before they can recruit new blood vessels through angiogenesis, will often have zones with very low amounts of oxygen. Therefore, in this case, the use of anaerobic metabolism seems to be a simple consequence of the lack of oxygen.

However, cancer cells will still use anaerobic metabolism even if oxygen is plentiful, so a lack of oxygen is not the only reason. The hypothesis that the mitochondria of cancer cell may somehow be damaged could be one explanation. Indeed, the mitochondria are important regulators of programmed cell death (apoptosis), and cancer cells must inactivate apoptosis in order to survive. Perhaps inactivation of apoptosis somehow compromises the ability of the mitochondria to perform aerobic metabolism.

Another hypothesis has to do with thinking about the anabolic pathways (those that build cellular components) as well as the catabolic pathways (those that produce energy) in metabolism. Many of the intermediates produced during glycolysis serve as the starting points for the synthesis of vital cellular components: lipids, amino acids, nucleotides, etc. By shuttling more material through glycolysis, cancer cells may be optimizing their capabilities to build more material at the expense of producing energy less efficiently (see Vander Heiden, Cantley, and Thompson (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324: 1029. http://dx.doi.org/10.1126/science.1160809 PMC2849637).

Finally, many cells in early development show "Warburg-like" metabolism, indicating that the metabolic state of cancer cells could merely be an effect of activating the same proliferative signalling pathways that are active in early development.
 

1. Do all tumors have functioning mitochondria?

No, not all tumors have functioning mitochondria. In fact, some tumors have dysfunctional mitochondria or no mitochondria at all. This is due to the unique characteristics and mutations of each type of tumor.

2. How do functioning mitochondria affect tumor growth?

Functioning mitochondria play a crucial role in tumor growth by providing energy for cell division and promoting cell survival. They also contribute to the production of reactive oxygen species, which can promote tumor growth and invasiveness.

3. Can targeting mitochondria be an effective treatment for tumors?

Targeting mitochondria has shown potential as a treatment for tumors. Some studies have shown that inhibiting mitochondrial function can lead to tumor cell death, while others have found that promoting mitochondrial dysfunction can suppress tumor growth. However, more research is needed to fully understand the effectiveness of this approach.

4. Are there any known links between mitochondrial DNA mutations and tumors?

Yes, there is evidence that mutations in mitochondrial DNA can contribute to the development and progression of tumors. These mutations can affect the functioning of mitochondria, leading to an increase in reactive oxygen species and promoting tumor growth.

5. Can changes in mitochondrial function be used as a biomarker for tumor development?

There is ongoing research on using changes in mitochondrial function as a biomarker for tumor development. Some studies have found altered mitochondrial function in early stages of tumor development, suggesting that it could potentially be used as a diagnostic tool. However, more research is needed to validate this approach.

Back
Top